Resignation of top Pharma lobbyist reveals deep corruption of health care reform process
May 12, 2010
By Ethan A. Huff
The President and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA), Billy Tauzin, recently announced that he will be resigning from the organization on June 30, 2010. The organization, which represents top drug companies like Pfizer and Merck, has been one of the primary backers of the Democrats' health care reform legislation, making Tauzin's resignation a significant setback.
Considered by many as a vital catalyst for getting the legislation passed, Tauzin guided PhRMA into a deal with the Obama Administration and top Senate Democrats to pay $80 billion over 10 years in the form of price cuts and other concessions in exchange for the 30 million or more new customers who would be added to the government insurance plan. Read more